But for many people, the first signs of progress e.g reduced appetite and early weight loss show up within the first two months of taking Zepbound
Compounded semaglutide is a once-weekly injectable medication whose active ingredient is semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist
Appetite for both meat and dairy is impacted slightly, with GLP-1 users eating dairy and meat less often, according to the data
Listed vial and specification formats for this series: 2mg*10Vials 5mg*10Vials 10mg*10Vials 15mg*10Vials 20mg*10Vials 30mg*10Vials 40mg*10Vials 50mg*10Vials 60mg*10Vials 80mg*10Vials 100mg*10Vials 120mg*10Vials
[20] [21] Seek urgent medical advice if you are already taking a GLP-1 medication and experience: Severe, persistent abdominal pain (possible pancreatitis) A new lump in your neck or changes in your voice Symptoms of severe hypoglycaemia (if taking other diabetes medications) Signs of thyroid dysfunction despite stable levothyroxine therapy Persistent vomiting leading to dehydration or inability to take oral medications Severe right upper abdominal pain, fever or jaundice (possible gallbladder disease) Open communication with your healthcare team ensures that treatment decisions are individualised, evidence-based, and aligned with your health priorities
Brand pen rules do not apply